TipRanks
COSMOS Pharmaceutical Corporation (JP:3349)
:3349
Japanese Market
3349
COSMOS Pharmaceutical Corporation
RESEARCH TOOLSreports
Want to see JP:3349 full AI Analyst Report?

COSMOS Pharmaceutical Corporation (3349) Income Statement

1 Followers

COSMOS Pharmaceutical Corporation Income Statement

Last quarter (Q4 2026), COSMOS Pharmaceutical Corporation's total revenue was ¥289.20B, an increase of 11.61% from the same quarter last year. In Q4, COSMOS Pharmaceutical Corporation's net income was ¥9.30B. See COSMOS Pharmaceutical Corporation’s key income statements, including revenue, expenses, profit, and income.
Income Statement
May 26May 25May 24May 23May 22
Total Revenue
¥ 1.10T¥ 1.01T¥ 964.99B¥ 827.70B¥ 755.41B
Gross Profit
¥ 229.68B¥ 213.28B¥ 188.31B¥ 168.72B¥ 151.45B
Operating Expenses
¥ 187.33B¥ 172.88B¥ 156.81B¥ 138.59B¥ 121.65B
Depreciation and Amortization
¥ 24.58B¥ 22.23B¥ 19.92B¥ 17.37B¥ 15.11B
EBITDA
¥ 66.48B¥ 64.85B¥ 53.74B¥ 50.19B¥ 48.21B
Operating Income
¥ 42.35B¥ 40.40B¥ 31.50B¥ 30.13B¥ 29.80B
Other Income/Expenses
¥ 1.86B¥ 1.97B¥ 2.22B¥ 2.64B¥ 3.25B
Pretax Income
¥ 44.22B¥ 42.37B¥ 33.72B¥ 32.77B¥ 33.05B
Net Income
¥ 32.05B¥ 30.98B¥ 24.45B¥ 23.80B¥ 23.16B
Per Share Metrics
Basic EPS
¥ 404.33¥ 390.85¥ 308.61¥ 300.48¥ 292.37
Diluted EPS
¥ 404.33¥ 390.85¥ 308.61¥ 300.48¥ 292.37
Weighted Average Shares Outstanding
 79.26M 79.26M 79.24M 79.20M 79.20M
Weighted Average Shares Outstanding (Diluted)
 79.26M 79.26M 79.24M 79.20M 79.20M
Currency in JPY

COSMOS Pharmaceutical Corporation Earnings and Revenue History